FDA unveils drugs to receive expedited review in support of 'national priorities'
PositiveHealth

The FDA has announced a new initiative to expedite the review process for certain drugs that align with national priorities. This move is significant as it aims to accelerate access to essential medications, potentially improving public health outcomes and addressing urgent medical needs more swiftly.
— Curated by the World Pulse Now AI Editorial System